世界の股関節変形性股関節症鎮痛剤市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Hip Osteoarthritis Pain Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z07114 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、股関節変形性股関節症鎮痛剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。股関節変形性股関節症鎮痛剤の種類別市場規模（経口、注射、外用）、用途別市場規模（医療、パーソナルケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・股関節変形性股関節症鎮痛剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Johnson and Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射、外用 ・用途別分析2016年-2026年：医療、パーソナルケア ・股関節変形性股関節症鎮痛剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・股関節変形性股関節症鎮痛剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・股関節変形性股関節症鎮痛剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・股関節変形性股関節症鎮痛剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・股関節変形性股関節症鎮痛剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Hip Osteoarthritis Pain Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hip Osteoarthritis Pain Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Hip Osteoarthritis Pain Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Hip Osteoarthritis Pain Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Injection
External

Market segment by Application can be divided into
Medical Care
Personal Care

The key market players for global Hip Osteoarthritis Pain Drug market are listed below:
Pfizer
Johnson and Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Hip Osteoarthritis Pain Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hip Osteoarthritis Pain Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Hip Osteoarthritis Pain Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Hip Osteoarthritis Pain Drug Market Size & Forecast
1.4.1 Global Hip Osteoarthritis Pain Drug Sales in Value (2016-2026))
1.4.2 Global Hip Osteoarthritis Pain Drug Sales in Volume (2016-2026)
1.4.3 Global Hip Osteoarthritis Pain Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Hip Osteoarthritis Pain Drug Production Capacity Analysis
1.5.1 Global Hip Osteoarthritis Pain Drug Total Production Capacity (2016-2026)
1.5.2 Global Hip Osteoarthritis Pain Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hip Osteoarthritis Pain Drug Market Drivers
1.6.2 Hip Osteoarthritis Pain Drug Market Restraints
1.6.3 Hip Osteoarthritis Pain Drug Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Hip Osteoarthritis Pain Drug Product and Services
2.1.4 Pfizer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Johnson and Johnson
2.2.1 Johnson and Johnson Details
2.2.2 Johnson and Johnson Major Business
2.2.3 Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services
2.2.4 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services
2.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Hip Osteoarthritis Pain Drug Product and Services
2.4.4 Bayer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Hip Osteoarthritis Pain Drug Product and Services
2.5.4 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Hip Osteoarthritis Pain Drug Product and Services
2.6.4 Novartis Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Hip Osteoarthritis Pain Drug Product and Services
2.7.4 Sanofi Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Horizon Pharma
2.8.1 Horizon Pharma Details
2.8.2 Horizon Pharma Major Business
2.8.3 Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services
2.8.4 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Hip Osteoarthritis Pain Drug Product and Services
2.9.4 Abbott Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Hip Osteoarthritis Pain Drug Product and Services
2.10.4 Mylan Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Daiichi Sankyo
2.11.1 Daiichi Sankyo Details
2.11.2 Daiichi Sankyo Major Business
2.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services
2.11.4 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Hip Osteoarthritis Pain Drug Product and Services
2.12.4 TEVA Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Almatica Pharma
2.13.1 Almatica Pharma Details
2.13.2 Almatica Pharma Major Business
2.13.3 Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services
2.13.4 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Astellas Pharma
2.14.1 Astellas Pharma Details
2.14.2 Astellas Pharma Major Business
2.14.3 Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services
2.14.4 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Tide Pharmaceutical
2.15.1 Tide Pharmaceutical Details
2.15.2 Tide Pharmaceutical Major Business
2.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
2.15.4 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Iroko Pharmaceuticals
2.16.1 Iroko Pharmaceuticals Details
2.16.2 Iroko Pharmaceuticals Major Business
2.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services
2.16.4 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business
2.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
2.17.4 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Abiogen Pharma
2.18.1 Abiogen Pharma Details
2.18.2 Abiogen Pharma Major Business
2.18.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services
2.18.4 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Hip Osteoarthritis Pain Drug Sales by Manufacturer
3.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hip Osteoarthritis Pain Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Hip Osteoarthritis Pain Drug Manufacturer Market Share
3.4.2 Top 6 Hip Osteoarthritis Pain Drug Manufacturer Market Share
3.5 Global Hip Osteoarthritis Pain Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hip Osteoarthritis Pain Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hip Osteoarthritis Pain Drug Market Size by Region
4.1.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Hip Osteoarthritis Pain Drug Revenue by Region (2016-2026)
4.2 North America Hip Osteoarthritis Pain Drug Revenue (2016-2026)
4.3 Europe Hip Osteoarthritis Pain Drug Revenue (2016-2026)
4.4 Asia-Pacific Hip Osteoarthritis Pain Drug Revenue (2016-2026)
4.5 South America Hip Osteoarthritis Pain Drug Revenue (2016-2026)
4.6 Middle East and Africa Hip Osteoarthritis Pain Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Type (2016-2026)
5.2 Global Hip Osteoarthritis Pain Drug Revenue by Type (2016-2026)
5.3 Global Hip Osteoarthritis Pain Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Application (2016-2026)
6.2 Global Hip Osteoarthritis Pain Drug Revenue by Application (2016-2026)
6.3 Global Hip Osteoarthritis Pain Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hip Osteoarthritis Pain Drug Sales by Type (2016-2026)
7.2 North America Hip Osteoarthritis Pain Drug Sales by Application (2016-2026)
7.3 North America Hip Osteoarthritis Pain Drug Market Size by Country
7.3.1 North America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Hip Osteoarthritis Pain Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hip Osteoarthritis Pain Drug Sales by Type (2016-2026)
8.2 Europe Hip Osteoarthritis Pain Drug Sales by Application (2016-2026)
8.3 Europe Hip Osteoarthritis Pain Drug Market Size by Country
8.3.1 Europe Hip Osteoarthritis Pain Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Hip Osteoarthritis Pain Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Hip Osteoarthritis Pain Drug Market Size by Region
9.3.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hip Osteoarthritis Pain Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hip Osteoarthritis Pain Drug Sales by Type (2016-2026)
10.2 South America Hip Osteoarthritis Pain Drug Sales by Application (2016-2026)
10.3 South America Hip Osteoarthritis Pain Drug Market Size by Country
10.3.1 South America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Hip Osteoarthritis Pain Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Hip Osteoarthritis Pain Drug Market Size by Country
11.3.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hip Osteoarthritis Pain Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hip Osteoarthritis Pain Drug Typical Distributors
12.3 Hip Osteoarthritis Pain Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Hip Osteoarthritis Pain Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hip Osteoarthritis Pain Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Hip Osteoarthritis Pain Drug Product and Services
Table 6. Pfizer Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson and Johnson Major Business
Table 9. Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services
Table 10. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services
Table 14. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Hip Osteoarthritis Pain Drug Product and Services
Table 18. Bayer Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Hip Osteoarthritis Pain Drug Product and Services
Table 22. Eli Lilly Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Hip Osteoarthritis Pain Drug Product and Services
Table 26. Novartis Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Hip Osteoarthritis Pain Drug Product and Services
Table 30. Sanofi Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Horizon Pharma Major Business
Table 33. Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 34. Horizon Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Abbott Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Hip Osteoarthritis Pain Drug Product and Services
Table 38. Abbott Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Hip Osteoarthritis Pain Drug Product and Services
Table 42. Mylan Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi Sankyo Major Business
Table 45. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services
Table 46. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. TEVA Basic Information, Manufacturing Base and Competitors
Table 48. TEVA Major Business
Table 49. TEVA Hip Osteoarthritis Pain Drug Product and Services
Table 50. TEVA Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Almatica Pharma Major Business
Table 53. Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 54. Almatica Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Astellas Pharma Major Business
Table 57. Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 58. Astellas Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Tide Pharmaceutical Major Business
Table 61. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 62. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Iroko Pharmaceuticals Major Business
Table 65. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services
Table 66. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Hengrui Pharmaceutical Major Business
Table 69. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 70. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table 72. Abiogen Pharma Major Business
Table 73. Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 74. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Hip Osteoarthritis Pain Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 76. Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Hip Osteoarthritis Pain Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Hip Osteoarthritis Pain Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Hip Osteoarthritis Pain Drug Production Site of Key Manufacturer
Table 80. Global Hip Osteoarthritis Pain Drug Sales by Region (2016-2021e) & (K Units)
Table 81. Global Hip Osteoarthritis Pain Drug Sales by Region (2021-2026) & (K Units)
Table 82. Global Hip Osteoarthritis Pain Drug Revenue by Region (2016-2021e) & (USD Million)
Table 83. Global Hip Osteoarthritis Pain Drug Revenue by Region (2021-2026) & (USD Million)
Table 84. Global Hip Osteoarthritis Pain Drug Sales by Type (2016-2021e) & (K Units)
Table 85. Global Hip Osteoarthritis Pain Drug Sales by Type (2021-2026) & (K Units)
Table 86. Global Hip Osteoarthritis Pain Drug Revenue by Type (2016-2021e) & (USD Million)
Table 87. Global Hip Osteoarthritis Pain Drug Revenue by Type (2021-2026) & (USD Million)
Table 88. Global Hip Osteoarthritis Pain Drug Price by Type (2016-2021e) & (USD/Unit)
Table 89. Global Hip Osteoarthritis Pain Drug Price by Type (2021-2026) & (USD/Unit)
Table 90. Global Hip Osteoarthritis Pain Drug Sales by Application (2016-2021e) & (K Units)
Table 91. Global Hip Osteoarthritis Pain Drug Sales by Application (2021-2026) & (K Units)
Table 92. Global Hip Osteoarthritis Pain Drug Revenue by Application (2016-2021e) & (USD Million)
Table 93. Global Hip Osteoarthritis Pain Drug Revenue by Application (2021-2026) & (USD Million)
Table 94. Global Hip Osteoarthritis Pain Drug Price by Application (2016-2021e) & (USD/Unit)
Table 95. Global Hip Osteoarthritis Pain Drug Price by Application (2021-2026) & (USD/Unit)
Table 96. North America Hip Osteoarthritis Pain Drug Sales by Country (2016-2021e) & (K Units)
Table 97. North America Hip Osteoarthritis Pain Drug Sales by Country (2021-2026) & (K Units)
Table 98. North America Hip Osteoarthritis Pain Drug Revenue by Country (2016-2021e) & (USD Million)
Table 99. North America Hip Osteoarthritis Pain Drug Revenue by Country (2021-2026) & (USD Million)
Table 100. North America Hip Osteoarthritis Pain Drug Sales by Type (2016-2021e) & (K Units)
Table 101. North America Hip Osteoarthritis Pain Drug Sales by Type (2021-2026) & (K Units)
Table 102. North America Hip Osteoarthritis Pain Drug Sales by Application (2016-2021e) & (K Units)
Table 103. North America Hip Osteoarthritis Pain Drug Sales by Application (2021-2026) & (K Units)
Table 104. Europe Hip Osteoarthritis Pain Drug Sales by Country (2016-2021e) & (K Units)
Table 105. Europe Hip Osteoarthritis Pain Drug Sales by Country (2021-2026) & (K Units)
Table 106. Europe Hip Osteoarthritis Pain Drug Revenue by Country (2016-2021e) & (USD Million)
Table 107. Europe Hip Osteoarthritis Pain Drug Revenue by Country (2021-2026) & (USD Million)
Table 108. Europe Hip Osteoarthritis Pain Drug Sales by Type (2016-2021e) & (K Units)
Table 109. Europe Hip Osteoarthritis Pain Drug Sales by Type (2021-2026) & (K Units)
Table 110. Europe Hip Osteoarthritis Pain Drug Sales by Application (2016-2021e) & (K Units)
Table 111. Europe Hip Osteoarthritis Pain Drug Sales by Application (2021-2026) & (K Units)
Table 112. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2016-2021e) & (K Units)
Table 113. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2021-2026) & (K Units)
Table 114. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue by Region (2016-2021e) & (USD Million)
Table 115. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue by Region (2021-2026) & (USD Million)
Table 116. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Type (2016-2021e) & (K Units)
Table 117. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Type (2021-2026) & (K Units)
Table 118. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Application (2016-2021e) & (K Units)
Table 119. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Application (2021-2026) & (K Units)
Table 120. South America Hip Osteoarthritis Pain Drug Sales by Country (2016-2021e) & (K Units)
Table 121. South America Hip Osteoarthritis Pain Drug Sales by Country (2021-2026) & (K Units)
Table 122. South America Hip Osteoarthritis Pain Drug Revenue by Country (2016-2021e) & (USD Million)
Table 123. South America Hip Osteoarthritis Pain Drug Revenue by Country (2021-2026) & (USD Million)
Table 124. South America Hip Osteoarthritis Pain Drug Sales by Type (2016-2021e) & (K Units)
Table 125. South America Hip Osteoarthritis Pain Drug Sales by Type (2021-2026) & (K Units)
Table 126. South America Hip Osteoarthritis Pain Drug Sales by Application (2016-2021e) & (K Units)
Table 127. South America Hip Osteoarthritis Pain Drug Sales by Application (2021-2026) & (K Units)
Table 128. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Country (2016-2021e) & (K Units)
Table 129. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Country (2021-2026) & (K Units)
Table 130. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue by Country (2016-2021e) & (USD Million)
Table 131. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue by Country (2021-2026) & (USD Million)
Table 132. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Type (2016-2021e) & (K Units)
Table 133. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Type (2021-2026) & (K Units)
Table 134. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Application (2016-2021e) & (K Units)
Table 135. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Application (2021-2026) & (K Units)
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Hip Osteoarthritis Pain Drug Typical Distributors
Table 139. Hip Osteoarthritis Pain Drug Typical Customers
List of Figures
Figure 1. Hip Osteoarthritis Pain Drug Picture
Figure 2. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. External
Figure 6. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2020
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Global Hip Osteoarthritis Pain Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Hip Osteoarthritis Pain Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Hip Osteoarthritis Pain Drug Sales (2016-2026) & (K Units)
Figure 31. Global Hip Osteoarthritis Pain Drug Production Capacity (2016-2026) & (K Units)
Figure 32. Global Hip Osteoarthritis Pain Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Hip Osteoarthritis Pain Drug Market Drivers
Figure 34. Hip Osteoarthritis Pain Drug Market Restraints
Figure 35. Hip Osteoarthritis Pain Drug Market Trends
Figure 36. Global Hip Osteoarthritis Pain Drug Sales Market Share by Manufacturer in 2020
Figure 37. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Manufacturer in 2020
Figure 38. Hip Osteoarthritis Pain Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Hip Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Hip Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Hip Osteoarthritis Pain Drug Sales Market Share by Region (2016-2026)
Figure 42. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2016-2026)
Figure 43. North America Hip Osteoarthritis Pain Drug Revenue (2016-2026) & (USD Million)
Figure 44. Europe Hip Osteoarthritis Pain Drug Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue (2016-2026) & (USD Million)
Figure 46. South America Hip Osteoarthritis Pain Drug Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue (2016-2026) & (USD Million)
Figure 48. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type (2016-2026)
Figure 49. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Type (2016-2026)
Figure 50. Global Hip Osteoarthritis Pain Drug Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2016-2026)
Figure 52. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application (2016-2026)
Figure 53. Global Hip Osteoarthritis Pain Drug Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Hip Osteoarthritis Pain Drug Sales Market Share by Country (2016-2026)
Figure 55. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2016-2026)
Figure 56. North America Hip Osteoarthritis Pain Drug Sales Market Share by Type (2016-2026)
Figure 57. North America Hip Osteoarthritis Pain Drug Sales Market Share by Application (2016-2026)
Figure 58. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Country (2016-2026)
Figure 59. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2016-2026)
Figure 60. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Type (2016-2026)
Figure 61. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Hip Osteoarthritis Pain Drug Sales Market Share by Country (2016-2026)
Figure 67. South America Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2016-2026)
Figure 68. South America Hip Osteoarthritis Pain Drug Sales Market Share by Type (2016-2026)
Figure 69. South America Hip Osteoarthritis Pain Drug Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

---